The Myopia Mindset

Most doctors stop at corneal ortho-k.
This episode starts where that comfort zone ends.

In Part 1 of this two-part series, host Matthew Herzberg is joined by Dr. Anith Pillai and Dr. Matthew Martin to break down trans-limbal ortho-k—what it is, what it is not, and why it’s quietly transforming how experienced clinicians approach adult, hyperopic, and high-challenge cases.

In Part 1, we cover:

What “trans-limbal” actually means—and why the distinction matters

Why larger diameters improve centration and comfort, particularly in adults

How lens mass and design give you more control over tissue manipulation

Why this approach is off-label—and how experienced doctors manage expectations without fear

The types of patients who benefit most (and who absolutely should not be fit)

In this episode of The Myopia Mindset, host Matthew Herzberg is joined by Dr. Ashley Tucker and Dr. Kevin Chan, co-editors of Review of Myopia Management, to break down the most important myopia management stories of 2025.

From evolving clinical protocols and risk stratification models, to emerging insights into retinal neurotransmitters, dopamine pathways, and evidence-based patient communication, this episode is designed to help optometrists stay ahead of where myopia care is going — not where it’s been.

If you want to grow into a confident, evidence-driven myopia management expert, this episode provides the context, nuance, and clinical relevance that matter most.

The Articles discussed in this episode are from Review of Myopia Management

1. https://reviewofmm.com/the-proliferation-of-myopia-management-spectacles

2. https://reviewofmm.com/how-to-manage-progressive-myopia-in-young-adults

3.https://reviewofmm.com/comparison-of-performance-of-myopia-control-spectacles-in-european-children

4. https://reviewofmm.com/the-latest-in-red-light-therapy

5. https://reviewofmm.com/retinal-neurotransmitter-systems-in-myopia-understanding-the-role-of-dopamine-and-related-pathways

6. https://reviewofmm.com/the-lipson-koffler-myopia-management-treatment-protocol

7. https://reviewofmm.com/20-20-20-rule/

8. https://reviewofmm.com/a-wake-up-call-regulatory-changes-for-red-light-therapy-china

9. https://reviewofmm.com/now-what-turning-essilors-stellest-approval-into-action/

10. https://reviewofmm.com/the-economics-of-myopia-management-2/

In this episode of Myopia Mindset, host Matthew Herzberg brings together a panel of leading voices in myopia management to tackle one of the most difficult—and most important—topics in pediatric care: visual hygiene.

Become a supporter to get the full episode: https://myopiamindset.substack.com/

An 11-year longitudinal study doesn’t just confirm the clinical value of orthokeratology—it explicitly acknowledges the real-world impact of myopia on productivity, lifestyle, and life trajectory.

🌟 Want the full episode? Become a paid supporter of The Myopia Mindset and unlock full episodes + monthly bonus content: 👉 https://myopiamindset.substack.com/

Myopia isn’t a clinician-only problem. And it isn’t an industry-only solution. This episode explores why solving myopia requires everyone at the table. Myopia is accelerating globally — and no single group can solve it alone. In this episode of The Myopia Mindset, host Matthew Herzberg sits down with a Tony Sommer for an honest, clinician-first conversation about what “all hands on deck” really means in myopia care.

Post-LASIK corneas demand different rules — and most failures happen before the lens is ever ordered. In this essential edition episode of Myopia Mindset, the focus is squarely on Post-LASIK Ortho-K — and why these cases fail long before lens design ever begins.

🌟 Want the full episode? Become a paid supporter of The Myopia Mindset and unlock full episodes + monthly bonus content:

👉 https://myopiamindset.substack.com/

What really determines success—or failure—in orthokeratology? In this Q&A section from the episode - Orthokeratology Fundamentals: "Diameter, Design & Myopia Control | Expert Roundtable" of the Myopia Mindset. Host Matthew Herzberg is joined by global leaders in myopia management and orthokeratology to break down the most overlooked elements of ortho-k lens design.

🌟 Want the full episode? Become a paid supporter of The Myopia Mindset and unlock full episodes + monthly bonus content: 👉 https://myopiamindset.substack.com/

Welcome back to The Myopia Mindset, your weekly check-in for motivation, education, and inspiration on your path to success with myopia management. Hosted by Matthew Herzberg, this episode features two rising stars in the myopia world: Dr. Zachary Holland and Dr. Joelle Holland. You may have seen them speak at Vision by Design, where their shared lecture showcased two unique practice styles, two different fitting philosophies, and one shared mission: transform the landscape of myopia management.

SUPPORT THE PODCAST Get early episodes, extended interviews, and exclusive monthly bonus content: https://www.myopiamindset.com/

Optometry and ophthalmology have a complicated past — but the future looks completely different. Recently both optometry (via the AAOMC) and ophthalmology (via AAPOS) have vocalized public positions on managing pediatric progressive myopia.

In this episode of The Myopia Mindset, host Matthew Herzberg sits down with two leaders shaping that future: Dr. Cheryl Chapman, orthokeratologist, myopia specialist, Past President of AAOMC Dr. Brandon Baartman, board-certified ophthalmologist at Vance Thompson Vision

This conversation was inspired by Brandon’s lectures at Vision by Design 2024, where Matthew realized just how far the OD–MD relationship has evolved. Together, Cheryl and Brandon unpack:

Why ophthalmology historically ignored (or even dismissed) myopia management

What’s changing — and why younger MDs think differently

How Cheryl and Brandon built their own interdisciplinary referral partnership

Why orthokeratology is no longer “snake oil” to MDs

How ODs can confidently approach ophthalmologists to build relationships

There is no shortage of myopic patients, but there is a shortage of strong OD–MD relationships.

If we’re going to slow the global rise of myopia, everyone in eyecare needs to work together.

There is a mandatory visual element to this episode, check out the YouTube version here: https://www.youtube.com/watch?v=78kOOo2iZCg

Learn how ethnicity, age, environment, and axial length all play critical roles in predicting progression—and why sometimes the most important choice is knowing when not to treat.

In this special “lecture-style” episode, series regular Dr. Matthew Martin walks through The Good, The Bad, and The Ugly of real-world myopia management. From early onset cases to long-term ortho-k outcomes, he covers:

🔹 Case 1: “Mini-Me” – A 6-year-old with early risk factors. When should you start?

🔹 Case 2: “Don’t Stop ‘Til You Get Enough” – An 11-year-old who stopped orthok and ended up with less myopia. How?

🔹 Case 3: “It’s Raining Cats and Dogs” – Managing allergies, comfort, and ortho success in active kids.

🔹 Case 4: “Wet Cement” – The pitfalls of missing subtle corneal findings in adults. Dr. Martin also shares: Why axial length trumps refraction as a key metric

How to structure fees for sustainability When to use (or avoid) low-dose atropine And the one thing you must check before fitting an orthok patient

🎧 Get the extended edition with audience Q&A and follow-up discussion at MyopiaMindset.com If you enjoy the show, please:

✅ Leave a 5-star review

✅ Share this episode with a colleague

✅ Follow us for more insights into building your myopia management practice

📧 Questions or comments? Email us: [email protected]